News Archive

EUSA Pharma appoints
Chief Financial Officer

18 March 2009.
Doylestown PA, USA and Oxford, UK - EUSA Pharma Inc (‘EUSA’), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care,announced today the appointment of David Cook to the newly-created role of Chief Financial Officer. Mr Cook will split his time between EUSA’s headquarters in the USA and the UK.

Mr Cook, who previously held the position of Finance Director at EUSA, has considerable expertise in financial management, business development and fund raising, developed during a career spanning nearly 20 years. Prior to joining the company, he was acting Chief Financial Officer for Zeneus Pharma, having been promoted from the role of Group Financial Controller. Previously, Mr Cook worked for PricewaterhouseCoopers for more than 10 years in a number of international roles in the UK and Australia, focusing on audit, transactional services and management consultancy. He holds a BA (Hons) degree in Chemistry from the University of Oxford and is a qualified chartered accountant.

“I want to warmly congratulate David on his appointment as Chief Financial Officer,” said
Bryan Morton, Chief Executive of EUSA Pharma. “The company has made tremendous progress since it was founded just over 2 years ago, having completed 4 major acquisitions and raising over $275 million. David has made a significant contribution to that growth, taking ownership of many key business development activities in addition to managing EUSA’s operational finances. David’s appointment is particularly welcome as it marks a scaling up of EUSA’s ambition to become one of the leading specialty companies in our field.”

Commenting on his appointment, David Cook, EUSA’s Chief Financial Officer, said, “Having completed the construction of a robust commercial infrastructure on both sides of the Atlantic, this is a tremendously exciting time for EUSA. Few companies have the unique combination of specialist medical and geographic focus that we have built, and I look forward to helping leverage that position in my new role as we continue our rapid progress towards
becoming a major international business.”

Download PDF
of transcript (28KB)